** Shares of Australia's Nanosonics NAN.AX rise 13.3% to A$4.95; their highest since August 14, 2023
** NAN says the U.S. Food and Drug Administration has granted De Novo clearance for its latest innovation, the CORIS system
** CORIS is an advanced cleaning system engineered to address one of the most critical challenges in medical device reprocessing: the effective cleaning of flexible endoscopes
** Stock up 61.5% YTD
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.